Abstract
Assessing long-term safety and efficacy of osilodrostat in prior- and new-use patients with endogenous cushing's syndrome: a 1-year real-world interim analysis of the non-interventional, multinational LINC 6 study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
